OncomiR-138 targets genes involved in senescence and its inhibition induces growth arrest of malignant gliomas.
Glioblastoma Multiforme (GBM) is the most aggressive types of brain cancer with a median lifespan of 12 months. Recent studies have reported elevated expression of miR-138 in Glioma Stem cells (GSCs) and demonstrated that knocking miR-138 down prevented tumor progression, though the exact downstream...
Saved in:
Main Author: | Malini Rethnam. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Final Year Project |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/52897 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
by: Di Pascale, F., et al.
Published: (2021) -
TRANSCRIPTIONAL REGULATION OF ONCOMIR-138 IN MALIGNANT GLIOMAS
by: DI PASCALE FEDERICA
Published: (2017) -
MiR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis
by: Silber J., et al.
Published: (2020) -
Antiangiogenic therapy in malignant glioma: Promise and challenge
by: Sith Sathornsumetee, et al.
Published: (2018) -
Medical oncology: Treatment and management of malignant gliomas
by: Deric M. Park, et al.
Published: (2018)